Wednesday, November 16, 2016
Print Current Session:
|
|
Wednesday
SESSION 26:
MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs); DEALING WITH COMPLEX LESIONS AND TRIALS
Moderators:Michael S. Conte, MD / John R. Laird, MD
|
|
SESSION 26 SCHEDULE | |
10:13 AM - 10:18 AM | Basic Principles And Constraints Of Various Drug Delivery Systems: They Are Not Simple And Details Matter: Why Leaving No Hardware Behind Is Important |
Presenter(s):William A. Gray, MD | |
View Slides in PDF | |
10:19 AM - 10:24 AM | DEBATE: How Best To Manage Complex Femoropopliteal Lesions: A Vascular Surgeon’s Perspective |
Presenter(s):Scott L. Stevens, MD | |
View Slides in PDF | |
10:25 AM - 10:30 AM | DEBATE: How Best To Manage Complex Femoropopliteal Lesions: An Interventionalist’s Perspective |
Presenter(s):Ulrich Beschorner, MD / Thomas Zeller, MD | |
View Slides in PDF | |
UPDATE ON DRUG COATED BALLOONS (DCBS | |
10:31 AM - 10:36 AM | Current Status, Limitations And Future Prospects For DCBs In Treatment Of Lower Extremity Ischemia: Are Their Benefits Sustained Mid- And Long-Term |
Presenter(s):Gunnar Tepe, MD | |
View Slides in PDF | |
10:37 AM - 10:42 AM | 3-Year Results Of The IN.PACT SFA Trial Comparing The In.Pact Admiral DCBs (Medtronic) With Standard Uncoated Balloons: Are The Benefits Of DCBs Over POBA Sustained |
Presenter(s):John R. Laird, MD / Peter A. Schneider, MD | |
View Slides in PDF | |
10:43 AM - 10:48 AM | Current Status, Value And Limitations Of DCBs In Fempop Occlusive Disease: Updates On The IN.PACT GLOBAL Registry And The LEVANT II Of The Lutonix DCB (Bard): Are The Benefits Over POBA Sustained |
Presenter(s):Dierk Scheinert, MD / Marianne Brodmann, MD | |
View Slides in PDF | |
10:49 AM - 10:54 AM | Importance Of Vessel Preparation With DCBs: Value Of Enforce Scoring Balloon (Cook) And Atherectomy With DCBs: Effect Of Calcium On DCBs Efficacy: Does The Lutonix DCB Work On BTK Arteries |
Presenter(s):Plinio Rossi, MD / Fabrizio Fanelli, MD, EBIR | |
View Slides in PDF | |
10:55 AM - 11:00 AM | Value Of The Legflow DCB vs. POBA For Long SFA Lesions: Proven By The RAPID RCT |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
11:01 AM - 11:06 AM | Panel Discussion |
Moderator(s): Dierk Scheinert, MD / Gunnar Tepe, MD | |
11:06 AM - 11:11 AM | An Update On The ILLUMENATE Trial Series: What Makes The Stellarex DCB Different |
Presenter(s):Sean P. Lyden, MD / Stefan Müller-Hülsbeck, MD / Marianne Brodmann, MD | |
View Slides in PDF | |
11:12 AM - 11:17 AM | Early Results Of The DRASTICO RCT Comparing DESs And DEBs For The Treatment Of Fempop Lesions |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
11:18 AM - 11:23 AM | What Is The Future Of DCBs In BTK And Crural Arteries: Why Some Of The RCTs Failed To Show A Benefit |
Presenter(s):Krishna J. Rocha-Singh, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | Why DCBs Have Not Worked Well For BTK Lesions, But They Will - Recent RCTs Prove It (Like The Aco ART BTK Trial With The LITOS DCB): Different DCB Platforms Have Different Efficacy Especially BTK: What Is The Future Of DCBs In Crural Arteries |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | DEBATE: Status Of The BEST-CLI Multicenter/Multispecialty Trial Comparing Endovascular And Open Surgical Treatment Of CLI: It Will Be A Valuable Trial That Settles Controversy |
Presenter(s):Matthew T. Menard, MD / Alik Farber, MD / Kenneth Rosenfield, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | DEBATE: Not So Fast: The BEST-CLI Trial May Not Be So Valuable And Here Is Why |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Slides in PDF | |
11:42 AM - 11:47 AM | Status Of DCBs In The US: What Is Available; What Will Be Available And When |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
11:48 AM - 11:53 AM | How To Calculate Fractional Flow Reserve (FFR) And Collateral Reserve In The Periphery Without Pressure Wires And How Should This Information Be Used In Treatment Decisions |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
previous | next |